Beta-blocker associated with better outcomes in treatment of infantile vascular tumors

Compared with oral corticosteroids, use of the beta-blocker propranolol for treatment of infantile hemangiomas was associated with higher rates of lesion clearance, fewer adverse effects, fewer surgical interventions after treatment, and lowers cost, according to a new report.

Read the whole article on Science Daily

More from Science Daily